Both surrogate markers used in our meta-analyses (HOMA index and fasting insulin) were classified to be inadequate in the assessment of insulin resistance in children and adolescents during a consensus conference on the topic in 2010 [37]. This evidence concerns the gene INS and Insulin resistance.